|
CRWENews.com Highlights: CLDA, SMSC, ACTG
(M2 PressWIRE Via Acquire Media NewsEdge) Las Vegas CRWENews.com reveals a stock highlight watch on Clinical Data, Inc., SMSC, Acacia Research Corporation receive FREE Stock-PR alerts from CRWENews.com. http://www.crwenewswire.com/?tag=stock-pr
Clinical Data, Inc. (NASDAQ: CLDA), today August 13, 2009 announced a collaboration and licensing agreement with CombinatoRx, Inc. to develop an adenosine A2A agonist compound in a combination therapy for the treatment of multiple myeloma, and other B-cell cancers. Under the agreement, Clinical Data licensed its highly selective adenosine A2A agonist, ATL313, to CombinatoRx in exchange for the potential to receive up to $252 million in clinical, regulatory and commercial milestones, as well as royalties on product sales. Clinical Data also retains a co-development option, which is exercisable after review of any Phase IIa study results.
SMSC (NASDAQ: SMSC), a leading semiconductor company that provides Smart Mixed-Signal Connectivity solutions, today August 13, 2009 introduced the LAN9303 and LAN9303M Ethernet switches. These devices are the industry's smallest fully-integrated, 3-port 10/100 managed Ethernet switches with support for single/dual MII/RMII/Turbo MII (Media Independent, Reduced Media Independent and Turbo Media Independent Interfaces).
Acacia Research Corporation (Nasdaq: ACTG) announced today August 13, 2009that its Data Network Storage LLC subsidiary has entered into a settlement and license agreement with Aberdeen LLC covering a patent portfolio that relates to storage area network technology. This agreement resolves patent litigation that was pending in the United States District Court for the Southern District of California.
About CRWENews.com
CRWENews.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENews.com is a division of Crown Equity Holdings, Inc.
CRWENews.com is not a registered investment advisor or broker-dealer. CRWENews.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
We encourage investors to join and receive FREE Stock-PR alerts from CRWENews.com. http://www.crwenewswire.com/?tag=stock-pr and view our full disclaimer.
Forward-Looking Statement: This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements and/or Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To IP Communications Global Community's Homepage ]
|
TMCnet LOGIN
Webinars
